"Keratinocyten - Proliferation
und differenzierte Leistung
in der Epidermis"
Publikationen
Der Arbeitsgruppe Tüting seit 01.01.1999
Tüting T, Gambotto A, Storkus WJ, De Leo AB. Co-delivery of T helper 1-biasing cytokine genes enhances the efficacy of gene gun immunization of mice: Studies with the model tumor antigen b-galactosidase and the BALB/c Meth A p53 tumor-specific antigen. Gene Ther 6: 629-636, 1999.
Sudowe S, Montermann E, Steitz J, Tüting T, Knop J, Reske-Kunz AB. Efficacy of recombinant adenovirus as vector for allergen gene therapy in a mouse model of type I allergy. Gene Ther, 9: 147-156, 2002.
Ross R, Sudowe S, Beisner J, Ross X-L, Steitz J, Tüting T, Knop J, Reske-Kunz AB. Induction of cellular immunity by DNA vaccination transcriptionally targeting dendritic cells. Zur Veröffentlichung eingereicht.
Steitz J, Brück J, Knop J, Tüting T. Adenovirus-transduced DC stimulate cellular immunity to melanoma via a CD4+ T cell-dependent mechanism. Gene Ther, 8: 1255-1263, 2001.
Steitz J, Brück J, Steinbrink K, Enk AH, Knop J, Tüting T (2000) Genetic immunization with human tyrosinase-related protein 2: implications for the immunotherapy of melanoma. Int J Cancer 86: 89-94.
Steitz J, Brück J, Gambotto A, Knop J, Tüting T. Genetic immunization with a melanocytic self-antigen linked to foreign helper sequences breaks tolerance and induces autoimmunity and tumor immunity. Gene Ther, 9: 208-213, 2002.
Tüting T, Steitz J, Brück J, Gambotto A, Steinbrink K, DeLeo AB, Robbins P, Knop J, Enk AH (1999) Dendritic cell-based genetic immunization in mice with a recombinant adenovirus encoding murine TRP2 induces effective anti-melanoma immunity. J Gene Med 1: 400-406
